Form 4 for VKTX Viking Therapeutics, Inc.
Accepted 2025-04-14 00:00:00 ET · period of report 2025-04-11 · accession 0000950170-25-053867 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-04-14 | 2025-04-11 | VKTX | FOEHR MATTHEW W | Dir | M - OptEx | $8.00 | +20.8K | 132.0K | +19% | +$166.3K |
| D | 2025-04-14 | 2025-04-11 | VKTX | FOEHR MATTHEW W | Dir | M - OptEx | $0.00 | -20.8K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.00001 per share | 2025-04-11 | M | A | 20,786 | $8.00 | 132,036 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2025-04-11 | M | D | 20,786 | $0.00 | 0 | D | $8.00 · 2016-05-26 to 2025-04-28 | 20,786 Common Stock |